This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.
CLSI NBS08
Original price was: $180.00.$90.00Current price is: $90.00.
Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E
Clinical and Laboratory Standards Institute , 10/28/2019
Pages: 130
